Responses
Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1373 STC-15, an oral small molecule inhibitor of the RNA methyltransferase METTL3, inhibits tumour growth through activation of anti-cancer immune responses and synergises with immune checkpoint blockade
Compose a Response to This Article
Other responses
No responses have been published for this article.